Value Proposition
@Roba Olana
- Point of care (field) testing ability
- The reliable detection of Bsal at low prevalence requires sampling a large number of individuals (DiGiacomo & Koepsell) and has therefore been expensive.
- Passive surveillance for infection in newts during their aquatic phase is unreliable, as hosts can carry infections asymptomatically (Stegen et al.), and dead newts quickly decompose in water.
- Temporal gap between sample collection and result significantly narrowed
- Data management(?)
- Power of full cycle involvement
- Use case varies widely and customizing our approach if need be or just simply being engaged with stakeholders lets us accomplish our goal at a greater scale.
Implication
- Current biosecurity methods are based on a PCR testing pathway that constitutes high costs and latent responses
- A newer diagnostic device would rewrite how we deal with infectious animal diseases
- Trying to retrofit the diagnostic device in existing protocols might not be beneficial